REVLIMID (lenalidomide) now available in UK for adult patients with previously untreated multiple myeloma who are not eligible for transplant

Celgene Limited, a wholly owned subsidiary of Celgene Corporation, has announced that REVLIMID (lenalidomide) is now available for adult patients with previously untreated multiple myeloma who...